Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Non-viral TcBuster transposon engineering of CD70-CAR natural killer cells for the treatment of osteosarcoma

Molecular Therapy Oncology(2025)10.1016/j.omton.2025.201119Source: DataRank Database

Non-viral TcBuster transposon engineering of CD70-CAR natural killer cells for the treatment of osteosarcoma is a research paper published in Molecular Therapy Oncology (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.00)OA: goldTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Jae‐Woong Chang,Joshua Krueger ORCID,Young Vue,Alexandria K. Gilkey,Timothy D. Folsom

Live enrichment

PubMed:41537165 PMC:PMC12796739 OpenAlex:https://openalex.org/W4417332110

U.S. Department of Defense

Grant: HT9425-24-1-0231

U.S. Department of Defense

Grant: HT9425-24-1-1002

U.S. Department of Defense

Grant: HT9425-24-1-1005

Randy Shaver Cancer Research and Community Fund

Grant: R21CA237789

Randy Shaver Cancer Research and Community Fund

Grant: R21AI163731

National Institutes of Health Office of the Director

Grant: F30OD030021

NIA NIH HHS

Grant: R61 AG090358

NCI NIH HHS

Grant: R37 CA276345

Children's Cancer Research Fund

Fanconi Cancer Foundation

National Institutes of Health

Office of the Director

FWCI

0.00

Citation Percentile

0.3%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.omton.2025.201119

publisherhttps://doi.org/10.1016/j.omton.2025.201119

publisherhttps://api.elsevier.com/content/article/PII:S2950329925001882?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2950329925001882?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41537165

Fields of Study

Immune Cell Function and InteractionCAR-T cell therapy researchImmunotherapy and Immune Responses

Keywords

Chimeric antigen receptorNK-92Homing (biology)Immune systemImmunotherapyAntigenInterleukin 12Lymphokine-activated killer cellCytokineOsteosarcomaTumor MicroenvironmentSolid TumorsAdoptive Cell TherapyCd70Tumor Immune EvasionTmeCar Nk CellsMetastatic OsteosarcomaMt: Regular IssueNk Cell PersistencePediatric Bone TumorRelapsed Osteosarcoma

Non-viral TcBuster transposon engineering of CD70-CAR natural killer cells for the treatment of osteosarcoma

FAIR Checklist

Authors (16)

Funding (12 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)